Pharmafile Logo
Pharmafocus logo
Advanced Search
Astrazeneca image

MRC gives £7 million to new projects

November 6, 2012
Sales and Marketing AstraZeneca, MRC, academics

The Medical Research Council (MRC) has handed out £7 million in funding for 15 research projects which will use a …

News
lilly image

New plant positions Lilly for changing insulin market

November 6, 2012
Manufacturing and Production Boehringer, insulin, lilly

Eli Lilly has unveiled plans for a $140 million expansion of its insulin plant in Indianapolis as it starts to …

News
Xarelto image

Further US approval for Xarelto

November 5, 2012
Sales and Marketing Eliquis, FDA, Pradaxa, Xarelto

US regulators have given the go-ahead to expand the indications for which Janssen Pharmaceuticals and Bayer HealthCare’s oral blood thinner …

News

Bayer to acquire Schiff Nutrition

November 4, 2012
Sales and Marketing Bayer, mergers and acquisitions

Bayer HealthCare is to buy US-based vitamins and nutritional supplements firm Schiff Nutrition International for $1.2 billion.The deal is part …

News

Pfizer stumbles in third quarter

November 2, 2012
Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3

Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …

News

Sanofi criticised for multiple sclerosis manoeuvres

November 2, 2012
Sales and Marketing Cancer, Lemtrada, MS, Sanofi

Sanofi is facing a backlash as it prepares its new MS treatment for the market. Lemtrada (alemtuzumab) has produced very …

News
screen_shot_2012-11-02_at_09

COPA-DATA appoints new UK managing director

November 2, 2012
Manufacturing and Production, Research and Development, Sales and Marketing COPA-DATA, Martyn Williams

Ergonomic process solutions firm COPA-DATA has appointed Martyn Williams as UK managing director with immediate effect. A qualified electronic engineer, …

Appointment
Novartis image

Novartis says Canada and Switzerland lift vaccines ban

November 2, 2012
Manufacturing and Production Canada, Novartis, Switzerland, vaccines

A temporary suspension on the distribution of flu vaccines made by Novartis has been lifted in Canada and Switzerland. The …

News
yervoy image

NICE hails ‘breakthrough’ skin cancer treatments

November 2, 2012
Sales and Marketing BMS, NICE, Roche, Yervoy, Zelboraf

Two new skin cancer drugs have been recommended by NICE, which hailed the drugs as ‘breakthrough treatments’. Bristol-Myers Squibb’s Yervoy …

News
Ameridose iamge

Meningitis probe extends to NECC sister company

November 1, 2012
Manufacturing and Production NECC, ameridose, meningitis

A second compounding pharmacy has been drawn into the investigation into the meningitis outbreak that has killed 29 people in …

News
mikem

Mike Mallinson joins The Access Partnership

November 1, 2012
Medical Communications, Sales and Marketing Mark Mallinson, The Access Partnership

Mike Mallinson has been appointed to lead communications firm The Access Partnership in the role of president. Mallinson is a …

Appointment
gsk image

GSK hit by European austerity again

November 1, 2012
Sales and Marketing Europe, GSK, Q3, austerity

GlaxoSmithKline suffered in the third quarter as sales fell 5% due to generic competition and austerity measures in Europe.Exceptional sales …

News

Novartis to build $500 million biotech facility in Singapore

November 1, 2012
Manufacturing and Production, Sales and Marketing Jimenez, M&P, Novartis, Singapore

Novartis is overseeing the construction of a biotechnology facility in Singapore that is the result of a $500m investment injection. …

News
peter_levantis

Inspired Science appoints principal medical writer

October 31, 2012
Medical Communications, Sales and Marketing Inspired Science, Peter Levantis

Med comms firm Inspired Science has announced the appointment of Dr Peter Levantis as principal medical writer. In this newly …

Appointment
sanofi image

Diabetes softens generics blow for Sanofi

October 30, 2012
Sales and Marketing Eloxatin, Plavix, Sanofi, diabetes, emerging markets, patent cliff

Sanofi has unveiled its results for the third quarter, with news that the damage done by patent expiries has not …

News

Lilly appoints new chief ethics and compliance officer and senior VP

October 30, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Melissa Barnes, lilly

Eli Lilly has announced that Melissa Barnes will be promoted to chief ethics and compliance officer and senior vice president …

Appointment

Canada latest country to suspend sales of Novartis vaccines

October 30, 2012
Manufacturing and Production Canada, Novartis, vaccines

Canada has said it will suspend sales of two flu vaccines made by Novartis – following in the footsteps of …

News

Shionogi and ViiV strike new HIV deal

October 30, 2012
Research and Development, Sales and Marketing Atripla, Dolutegravir, HIV, Shionogi, ViiV

HIV specialist firm ViiV Healthcare has announced a new deal with Japan’s Shionogi on a promising new treatment. ViiV Healthcare …

News

Pharmalink AB strengthens senior management

October 30, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Heather Cook, Marek Poszepczynski, Pharmalink AB

Pharmalink AB has appointed Heather Cook as director of Regulatory Affairs and Marek Poszepczynski as director of Business Development. Cook …

Appointment
Boehringer image

Boehringer to increase production of Respimat inhaler

October 30, 2012
Manufacturing and Production Boehringer Ingelheim, Respimat SMI, Soft Mist

Boehringer Ingelheim is investing €85 million in manufacturing capacity for its Respimat Soft Mist Inhaler in the face of growing …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026